DoW Melanoma Research Program Focused Program Award â Rare Melanomas
Dept. of the Army -- USAMRAA
Funding Amount
$5,600,000 total
Deadline
October 14, 2026
134 days left
Grant Type
federal
Overview
DoW Melanoma Research Program Focused Program Award â Rare Melanomas
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award â Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas. Distinctive Features: · Updated for FY26 Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact. · This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1 . Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). · After submitting the required pre-application, investigators must receive an invitation to submit a full application . Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)âs application is an abbreviated package specific to their proposed research project. · Clinical trials are allowed.
Details
- Agency: Dept. of the Army -- USAMRAA
- Department: Department of Defense
- Opportunity #: HT942526MRPFPARM
- Total Funding: $5,600,000
- Expected Awards: 2
- Instrument: grant
Eligibility
Eligible Applicant Types
Focus Areas & Funding Uses
Fields of Work
Categories
Browse similar grants by category
Related Grants
Similar grants from this funder and related organizations
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
September 7, 2026
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $499,000
Deadline
September 7, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
September 7, 2026
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
National Institutes of Health
Amount
Varies
Deadline
September 25, 2026
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $475,000
Deadline
Closed
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
Amount
Varies
Deadline
Closed
Ready to apply for DoW Melanoma Research Program Focused Program Award â Rare Melanomas?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found DoW Melanoma Research Program Focused Program Award â Rare Melanomas. Now let's win it.